<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Shaw | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/mindcousin8/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/mindcousin8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Shaw.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">d6c397e4aec12d0d71e10e9411e45679</guid>
				<title>Shaw posted an update: The method provided robust validation results with [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41990/</link>
				<pubDate>Sat, 08 Feb 2025 11:47:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>The method provided robust validation results with inaccuracy and imprecision values of ≤ 9.59 % and ≤ 11.1 % for all quality controls.</p>
<p> The presented method is suitable for accurate and simultaneous quantification of remdesivir, its metabolite GS-441525, chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azi&hellip;<span class="activity-read-more" id="activity-read-more-41990"><a href="http://www.nationalboardinstitute.com/activity/p/41990/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6d09fdaf720c2a2be6131b699125293b</guid>
				<title>Shaw posted an update: h type 2 diabetes with no retinopathy.



 To determine at [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38512/</link>
				<pubDate>Tue, 04 Feb 2025 11:47:40 -0800</pubDate>

									<content:encoded><![CDATA[<p>h type 2 diabetes with no retinopathy.</p>
<p> To determine at which phase in the recruitment process for participation in clinical research studies do health literacy and other patient characteristics influence recruitment outcomes.</p>
<p> Using a sample of 5872 patients hospitalized with cardiovascular disease approached for participation in the&hellip;<span class="activity-read-more" id="activity-read-more-38512"><a href="http://www.nationalboardinstitute.com/activity/p/38512/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4164c1cacba43b296bf1704d5eb704ba</guid>
				<title>Shaw posted an update: Objectives. To investigate lifestyle-related predictors of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36629/</link>
				<pubDate>Sun, 02 Feb 2025 11:28:52 -0800</pubDate>

									<content:encoded><![CDATA[<p>Objectives. To investigate lifestyle-related predictors of prediabetes and diabetes in young adults aged 20-39 years using data from the 2014-2016 Korea National Health and Nutrition Examination Survey (KNHANES). Methods. <a href="https://www.selleckchem.com/products/3-methyladenine.html" rel="nofollow ugc">3-MA price</a> This study is a cross-sectional, secondary analysis using the KNHANES data. Participants were classified into normal&hellip;<span class="activity-read-more" id="activity-read-more-36629"><a href="http://www.nationalboardinstitute.com/activity/p/36629/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3de4fd6355be04493d6357cd4cac24d0</guid>
				<title>Shaw posted an update: The profound knowledge of wEPT provided in our work will [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31526/</link>
				<pubDate>Tue, 28 Jan 2025 16:59:59 -0800</pubDate>

									<content:encoded><![CDATA[<p>The profound knowledge of wEPT provided in our work will benefit its performance in clinical applications.Reversine, or 2-(4-morpholinoanilino)-6cyclohexylaminopurine, is a 2,6-disubstituted purine derivative. This small molecule exhibits tumor-suppressive activities through different molecular mechanisms. In this study, in vitro and in vivo&hellip;<span class="activity-read-more" id="activity-read-more-31526"><a href="http://www.nationalboardinstitute.com/activity/p/31526/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e2fe145d163876102e52dc548b055b95</guid>
				<title>Shaw became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31490/</link>
				<pubDate>Tue, 28 Jan 2025 16:57:11 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>